Cargando…
Beyond genomics: understanding exposotypes through metabolomics
BACKGROUND: Over the past 20 years, advances in genomic technology have enabled unparalleled access to the information contained within the human genome. However, the multiple genetic variants associated with various diseases typically account for only a small fraction of the disease risk. This may...
Autores principales: | Rattray, Nicholas J. W., Deziel, Nicole C., Wallach, Joshua D., Khan, Sajid A., Vasiliou, Vasilis, Ioannidis, John P. A., Johnson, Caroline H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787293/ https://www.ncbi.nlm.nih.gov/pubmed/29373992 http://dx.doi.org/10.1186/s40246-018-0134-x |
Ejemplares similares
-
Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study
por: Liu, Patrick, et al.
Publicado: (2019) -
Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease
por: Wallach, Joshua D., et al.
Publicado: (2020) -
Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches
por: Rosen Vollmar, Ana K., et al.
Publicado: (2019) -
Urinary Paraben Concentrations and Associations with the Periconceptional Urinary Metabolome: Untargeted and Targeted Metabolomics Analyses of Participants from the Early Pregnancy Study
por: Rosen Vollmar, Ana K., et al.
Publicado: (2023) -
Improved drug therapy: triangulating phenomics with genomics and metabolomics
por: Monte, Andrew A, et al.
Publicado: (2014)